K. Harshita
{"title":"Drug-Receptor Interactions of New Isoxazole Scaffold against Breast and Skin Cancer Cell Lines","authors":"K. Harshita","doi":"10.5185/amp.2019.0007","DOIUrl":null,"url":null,"abstract":"The electron rich oxygen and nitrogen exists at 1, 2 positions in a five membered ring system is known as isoxazole, an active pharmacophore. They are reported to be interesting synthons to synthesize various useful scaffolds of interesting biological activities. Herein, we report the synthesis of isoxazoles from ethoxy substituted chalcone derivatives on reaction with hydroxylamine hydrochloride in basic medium. All the compounds are characterized by spectroscopic methods. The present study is an effort to extend the utility of virtual drug-receptor interaction of isoxazoles on the active site of target inhibitor bound cytochrome P450 family oxidoreductase [PDB: 3PM0] for breast cancer cell line and pirin inhibiting target [PDB: 3ACL] for skin cancer cell lines respectively. Both the chloro and bromo substituted derivatives showed maximum interactions with minimum docking scores. In silico ADME–toxicity evaluation to predict the preliminary pharmacokinetic and toxicity profile of the synthesized compounds is also conducted. Copyright © VBRI Press.","PeriodicalId":7297,"journal":{"name":"Advanced Materials Proceedings","volume":"125 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advanced Materials Proceedings","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5185/amp.2019.0007","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
新型异恶唑支架抗乳腺癌和皮肤癌细胞的药物受体相互作用
富电子的氧和氮在五元环体系中的1,2位被称为异恶唑,是一种活性药效团。据报道,它们是有趣的合成子,可以合成各种有趣的生物活性的有用支架。本文报道了以乙氧基取代查尔酮衍生物为原料,在碱性介质中与盐酸羟胺反应合成异恶唑。所有化合物都用光谱方法进行了表征。本研究旨在扩大异唑类药物与受体虚拟相互作用在靶抑制剂结合细胞色素P450家族氧化还原酶[PDB: 3PM0]对乳腺癌细胞系和皮林抑制靶点[PDB: 3ACL]对皮肤癌细胞系活性位点的应用。氯取代衍生物和溴取代衍生物均表现出最大的相互作用和最小的对接分数。还进行了硅片adme毒性评价,以预测合成化合物的初步药代动力学和毒性谱。版权所有©VBRI出版社。
本文章由计算机程序翻译,如有差异,请以英文原文为准。